Current through Vol. 42, No. 1, September 16, 2024
(a)
Preliminary review and assessment.
(1) Upon receipt of a completed application
for a proposed research project, a preliminary assessment of the application is
performed by the Oklahoma Department of Human Services Institution Review Board
(DHSIRB).
(2) The preliminary
assessment is completed by the chair or the Chair's designee. The assessment
determines if the applicant is seeking a full review, an expedited review, or
an exemption from review and ensures the provided documentation complies with
the pertinent application, per Oklahoma Administrative Code (OAC)
340:2-39-11.
(3) When the application is
incomplete in any way, the Chair or the Chair's designee notifies the applicant
and explains any deficiencies. The applicant is invited to re-submit the
application with deficiencies corrected.
(4) When the application is determined to be
complete, the Chair or the Chair's designee assigns a unique identifier number
to the proposed research project. This number is used in all future
correspondence with the applicant and/or investigator.
(5) When the chair determines the application
satisfactorily seeks an expedited review or exemption review, the application
and its materials are presented to the Vice-Chair and the DHSIRB Office of
Client Advocacy member for review.
(6) When the chair determines the application
requires a full review, the application and its materials are presented to all
DHSIRB members for review and consideration at the next DHSIRB meeting.
(7) When it is determined that
additional information and/or clarification is needed for an application's
review, the Chair or the Chair's designee notifies the applicant. The applicant
has 90-calendar days to respond.
(A) When the
applicant does not respond in a satisfactory manner to the request for
additional information and/or clarification within 90-calendar days, the DHSIRB
notifies the applicant that the application was administratively closed.
(B) An application that is
administratively closed may not be re-opened; however, a new application may be
submitted.
(b)
Determination that a proposed
research project is not human subjects research.
(1) When an investigator or researcher
submits an application with a request for a determination of not human subjects
research, the DHSIRB chair follows the procedures described in (A) and (B) of
this paragraph.
(A) The Chair convenes a
subcommittee consisting of the Chair, the Vice-Chair, and the Office of Client
Advocacy member.
(B) The
subcommittee reviews completed Form 0AD085E and the principal investigator's
justification why the proposed research does not qualify as human subjects
research.
(i) Based on this review, if the
subcommittee determines the proposed research project does not constitute human
subjects research, the Chair or the Chair's designee informs the applicant, in
writing, of the DHSIRB decision.
(ii) When the subcommittee determines that
the proposed research project does constitute human subjects research, the
Chair or the Chair's designee informs the applicant, in writing, of the DHSIRB
subcommittee decision. The applicant is directed to re-submit the application
with a request for an exempt, expedited, or full board review.
(2) DHSIRB members are
notified each time a research proposal is determined to not constitute human
subjects research. The information is presented electronically or in hard copy
format at the earliest possible DHSIRB regular meeting.
(3) If the investigator or researcher
disagrees with the DHSIRB decision, a request for reconsideration may be
submitted, per OAC
340:2-39-13(c).
(c)
Applications
with an exemption request.
(1) When an
investigator or researcher submits an application with a request for
recognition that his or her project is exempt from review, the DHSIRB chair
follows the procedures in (A) and (B) in this paragraph.
(A) The chair convenes a subcommittee
consisting of the Chair, the Vice-Chair, and the Office of Client Advocacy
member.
(B) The subcommittee
reviews the completed application and materials supporting the justification
why the research project is exempt from review.
(i) Based on this review, if the subcommittee
determines that the proposed research project is properly exempt from any
review, the Chair or the Chair's designee informs the applicant, in writing, of
the DHSIRB decision.
(ii) If the
subcommittee determines that the proposed research project is conditionally
exempt from DHSIRB review, the subcommittee must also conduct a limited review,
per (g) of this Section.
(I) The subcommittee
conducts a limited review when the proposed research is of a type described in
the federal regulations at Title
45 C.F.R. §
46.104(d)(2)(iii), (d)(3)(i)(C), (d)(7) or
(8).
(II) The subcommittee may conduct a limited
review when the subcommittee believes a limited review is necessary in order to
protect the privacy of subjects or to maintain the confidentiality of data or
to ensure broad consent was properly obtained and documented.
(iii) If the subcommittee
determines that the proposed research project is not exempt from a review, the
subcommittee proceeds with an expedited review of the project using the
procedures in (e) of this Section.
(2) Within 14-calendar days after the DHSIRB
action on the exemption request, the Chair or Chair's designee sends a written
notification informing the applicant of the determination. The written
notification includes:
(A) the unique
identifier DHSIRB number;
(B)
research name; and
(C) reason(s)
the exemption request was approved or denied.
(3) If the investigator or researcher
disagrees with the DHSIRB decision, a request for reconsideration may be
submitted, per OAC
340:2-39-13(c).
(4) The DHSIRB members are
notified each time a research proposal is approved through exemption. The
information is presented electronically or in hard copy format at the earliest
possible DHSIRB regular meeting.
(d)
Applications with a request for an
expedited review.
(1) When an
investigator or researcher submits an application with a request for an
expedited review, the DHSIRB Chair follows the procedures described in this
paragraph.
(A) The chair convenes a
subcommittee consisting of the Chair, Vice-Chair, and Office of Client Advocacy
member. The subcommittee reviews the completed application and assesses the
proposed research project based upon the criteria for an expedited review, per
OAC
340:2-39-11(e).
(i) Based on this review, if the subcommittee
determines that the proposed research project satisfies the criteria for an
expedited review, the subcommittee carries out the proposed project initial
review.
(I) The subcommittee may exercise all
DHSIRB authorities except disapproving research.
(II) When the subcommittee fails to accept
the research project for an expedited review, then the proposed research
project is reviewed in accordance with the non-expedited procedures described
in (e) of this Section.
(III) A
research project may be disapproved only after review in accordance with the
non-expedited procedure.
(ii) If the subcommittee determines that the
proposed research project does not meet the criteria for an expedited review,
the Chair presents the application to the DHSIRB for a non-expedited review at
the next scheduled meeting.
(B) The Director may restrict, suspend,
terminate, or choose not to authorize the DHSIRB's use of this expedited review
procedure.
(2) The
DHSIRB members are notified each time a research proposal is approved through
the use of this expedited process. Information about each expedited approval is
given to the DHSIRB members in a written report of expedited actions. The
report is presented in written or electronic form and disseminated to all board
members or at the earliest possible DHSIRB regular meeting. DHSIRB members are
given an opportunity to review the report of expedited actions. The review must
include an opportunity for members to ask questions or raise concerns about any
expedited action. A motion to accept or approve the report may be entertained.
(e)
Full review
of new research projects, non-exempt, non-expedited.
(1)
Review at a convened
meeting. Except when an expedited review procedure is used, per (d), the
DHSIRB performs an initial review of proposed new research projects at a
convened meeting when a quorum is present. In order for the research to be
approved, it must receive the approval of a majority of those members present
at the meeting.
(2)
Reliance
on the written application. To complete its review, the DHSIRB may
choose to rely solely on the written application, including attachments
submitted by the applicant.
(3)
Optional review of other information. In addition to its review of
the written application, including attachments, the DHSIRB may also choose to
invite:
(A) the primary investigator to
provide additional information;
(B) subject matter experts to assist in the
review; or
(C) experts and guests
to attend the meeting when the review takes place.
(4)
Review criteria. In order to
approve new research covered by this subsection, the DHSIRB determines, per
45 C.F.R. §
46.111 that the requirements in (A) through
(G) are satisfied.
(A) Risks to subjects are
minimized by using procedures:
(i) consistent
with sound research design and that do not unnecessarily expose subjects to
risk; and
(ii) already performed
on the subjects for diagnostic or treatment purposes, whenever appropriate.
(B) Risks are
reasonable in relation to anticipated benefits to subjects, if any, and the
importance of the knowledge that may be expected to be gained. In evaluating
risks and benefits, DHSIRB considers only those risks and benefits that may
result from the research as distinguished from risks and benefits of therapies
subjects would receive even if not participating in the research. Per
45 C.F.R. §
46.111(a)(2), DHSIRB does
not consider possible long-range effects of applying the knowledge gained in
the research.
(C) Selection of
subjects is equitable. In making this assessment the DHSIRB takes into account
the research purposes and the setting in which the research is conducted.
Additionally, the DHSIRB is particularly cognizant of the special problems of
research involving subjects who are likely to be vulnerable to coercion or
undue influence, such as children, prisoners, economically or educationally
disadvantaged persons, or individuals with impaired decision-making capacities.
(D) The proposed research includes
a plan to seek informed consent from each prospective participant or the
subject's legally authorized representative, per OAC 340:2-39-11.1.
(E) Informed consent is appropriately
documented or appropriately waived, per OAC 340:2-39-11.1.
(F) When appropriate, the research plan makes
adequate provision for monitoring the data collected to ensure the subjects'
safety.
(G) When appropriate,
there are adequate provisions to protect the subjects' privacy and maintain the
confidentiality of data.
(5)
Additional requirements. In
order to approve new research projects covered by this subsection the DHSIRB
reviews the investigator's qualifications to conduct and supervise the proposed
research. This process may include:
(A)
reviewing the investigators', sub-investigators', and other necessary research
staffs' resumes, verifying professional associations and licenses and may
include a review of the investigators' previous specific experience as
demonstrated by recent presentations or publications;
(B) using previous DHSIRB experience with the
investigators; and
(C) requesting
additional information confirming the investigators' qualifications from an
administrator of the investigators' institutions.
(f)
Review and approval of
cooperative research projects.
(1)
Cooperative research projects are those projects that involve the Oklahoma
Department of Human Services (DHS) as well as one or more additional
institutions.
(A) In the conduct of
cooperative research projects, DHSIRB and the other institution(s) are
responsible for safeguarding the rights and welfare of human subjects.
(B) DHSIRB makes arrangements with
the other institution(s) to avoid duplication of efforts.
(C) When a cooperative research project is
sponsored by a federal department or agency that is supporting or conducting
the research, DHSIRB relies on the federal department or agency to identify the
reviewing Institution Review Board (IRB).
(D) Consistent with the federal regulations,
per Title
45 C.F.R. §
46.114(b), DHSIRB recognizes
that any institution located in the United States (U.S.) engaged in cooperative
research must generally rely upon approval by a single IRB for the portion of
the research conducted in the U.S., unless:
(i) more than a single IRB review is required
by law, including tribal law passed by the official governing body of an
American Indian or Alaska Native tribe;
(ii) a federal department or agency
supporting or conducting the research determines and documents that the use of
a single IRB is not appropriate for the particular context; or
(iii) the cooperative research project does
not have a federal sponsor.
(2) When DHSIRB participates with another
institution in a cooperative research project that does not have a federal
sponsor, DHSIRB seeks to avoid duplication of effort by:
(A) entering into a joint review agreement
with the other institution;
(B)
relying on the review of the other institution's IRB; or
(C) making similar arrangements for avoiding
duplication of effort.
(g)
Limited reviews.
(1) If the DHSIRB affirms that a research
proposal meets the criteria for a conditional exemption from review, per OAC
340:2-39-12(c), the DHSIRB performs a limited review of the proposal.
(2) The scope of the limited
review depends on the type of research proposal. The four types of research are
in (A) through (D).
(A) Mildly obtrusive
interactions research, per
45 C.F.R. §
46.104(d)(2)(iii), is
defined as research with features in (i) and (ii) of this subparagraph.
(i) Mildly obtrusive interactions research
only includes interactions involving:
(I)
educational tests, such as cognitive, diagnostic, aptitude, and achievement
tests;
(II) survey procedures;
(III) interview procedures; or
(IV) observation of public
behavior, including visual or auditory recording; and
(ii) the information obtained is recorded by
the investigator so the human subjects' identity can readily be ascertained,
directly or through identifiers linked to the subjects.
(B) Benign behavioral interventions, per
45 C.F.R. §
46.104(d)(3)(i)(C), is
defined as research with features in (i) and (ii) of this subparagraph.
(i) Benign behavioral interventions involves
interventions in conjunction with the collection of information from an adult
subject through verbal or written responses, including data entry, or
audiovisual recording if the subject prospectively agrees to the intervention
and information collection.
(ii)
The information obtained is recorded by the investigator so the identity of the
human subjects can readily be ascertained, directly or through identifiers
linked to the subjects.
(C) Storage or maintenance for secondary
research for which broad consent is required, per
45 C.F.R. §
46.104(d)(7), is defined as
research involving the storage or maintenance of identifiable private
information or identifiable biospecimens for potential secondary research use.
(D) Secondary research for which
broad consent is required, per
45 C.F.R. §
46.104(d)(8), is defined as
research involving the use of identifiable private information or identifiable
biospecimens for secondary research use, when the conditions in (i) through
(iii) are present.
(i) Broad consent for the
storage, maintenance, and secondary research use of the identifiable private
information or identifiable biospecimens was obtained.
(ii) Documentation of informed consent or
waiver of documentation of consent was obtained, per OAC 340:2-39-11.1.
(iii) The investigator does not
include returning individual research results to subjects as part of the study
plan.
(3)
For mildly obtrusive interactions research and for benign behavioral
interventions, the DHSIRB review is limited to determining that there are
adequate provisions to protect the privacy of subjects and to maintain the
confidentiality of data.
(4) For
storage or maintenance for secondary research for which broad consent is
required, and for secondary research for which broad consent is required, the
DHSIRB review is limited to determining that:
(A) broad consent for storage, maintenance,
and secondary research use of identifiable private information or identifiable
biospecimens is obtained, per OAC 340:2-39-11.1(b);
(B) broad consent is appropriately documented
or waiver of documentation is appropriate, per OAC 340:2-39-11.1(d); and
(C) if there is a change made for
research purposes in the way the identifiable private information or
identifiable biospecimens are stored or maintained, there are adequate
provisions to protect the privacy of subjects and to maintain the
confidentiality of data.
(h)
Review and approval
notification.
(1)
Approval
categories. As a result of the DHSIRB review, each research proposal is
assigned to one of the categories in (A) through (E) of this paragraph.
(A)
Not human subjects research.
Proposal determined to not constitute human subjects research. Investigators
whose proposals receive this determination may begin work immediately.
(B)
Approved.
Research is approved as submitted. Investigators whose proposals are approved
may begin work immediately.
(C)
Conditionally approved. Research is conditionally approved, but
research may not begin until investigators comply with items identified by the
DHSIRB for final approval.
(D)
Deferred. DHSIRB does not have enough information to make a
determination. Investigators whose proposals receive a deferral must resubmit
the entire application to address the required changes.
(E)
Not approved. The magnitude
and/or number of concerns are such that conditional approval is not
appropriate. Investigators whose work is disapproved may not conduct the
research or resubmit their proposals.
(2)
Notification required. The
DHSIRB notifies investigators and appropriate managers, supervisors, and
directors within DHS in writing of its decision regarding the proposed research
activity, including any modifications or conditions required to secure DHSIRB
approval of the research activity.
(A)
Approved applications.
(i) At a
minimum, the approval letter contains:
(I)
the unique identifier DHSIRB number;
(II) the research name;
(III) the date of approval;
(IV) all reviewed and approved DHSIRB
documents;
(V) the duration of the
approval; and
(VI) circumstances,
such as adverse events or closure of the research, for which DHSIRB must be
contacted.
(ii) The
approval date is the date when the application is approved.
(iii) Continuing review is not required
except when there is a good reason for doing so, per OAC 340:2-39-12.2(c).
(B)
Conditionally
approved applications.
(i) A letter
describing the concerns of the DHSIRB is sent to the investigator. The letter
makes it clear the research may not begin until DHSIRB issues a letter of
approval.
(ii) Investigators have
90-calendar days from the day they are notified about the conditionally
approved research to respond. If a response is not received during this period,
investigators must resubmit the entire application.
(iii) To review the investigator's response,
the chair convenes a subcommittee consisting of the Chair, the Vice-Chair, and
the Office of Client Advocacy member. The subcommittee reviews the
investigator's response for appropriateness.
(iv) The subcommittee makes a determination
as to whether the response adequately addresses the DHSIRB concerns.
(v) A DHSIRB final approval letter is sent to
the investigator when the response is approved. At that time, the research may
begin. The approval date is the date the investigator's response is approved.
Continuing review is not required except when there is a good reason for doing
so, per OAC 340:2-39-12.2(c).
(C)
Deferred. A letter
describing the determination is sent to the investigator.
(D)
Not approved. A designation
of not approved indicates the magnitude and/or number of concerns is such that
conditional approval is not appropriate, as determined by the DHSIRB.
(i) A letter describing the DHSIRB decision
and concerns is sent to the investigator. The investigator is notified of the
opportunity to respond to the DHSIRB, in writing or in person, regarding the
determination, per OAC
340:2-39-13.
(ii) The DHSIRB accomplishes any
reconsideration in the same manner as the preliminary review and assessment
described in (a) of this Section.
(iii) The investigator is not advised to
resubmit disapproved research without consulting the DHSIRB.
(iv) In the event of a resubmission, the
DHSIRB submission is given a new number and addressed as a completely new
submission.
(3) In general, action on all proposals is
taken within two months after submission. Investigators are notified, in
writing, of the DHSIRB decisions within two weeks of board action.
(i)
Further reviews by
DHS. Research covered by this Part approved by the DHSIRB may be subject
to further appropriate review and approval or disapproval by DHS officials.
However, DHS officials may not approve the research if it was not approved by
the DHSIRB.